Micron Stock Surges to 1 Trillion Valuation on AI Optimism Qualcomm Gains on ByteDance Chip Deal Walmarts NonRetail Arm Emerges as Growth Engine but Premium Valuation Demands Proof Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Tensions Rise Salesforce Shares Slide as Revenue Outlook Disappoints Amid AI Competition Concerns Companies Continue to Expand Prediction Market Investments Amid Regulatory Uncertainty Mercury Achieves 52 Billion Valuation After 200M Funding Round Defying Fintech Downturn RLAY Q1 2026 Earnings EPS Misses Consensus PreRevenue Biotech Maintains RD Focus AutoZone Q1 2026 Earnings EPS Surpasses Estimates by 084 Stock Edges Lower GRPN Q1 2026 Earnings Significant EPS Miss Amid Strategic Challenges Stock Rises on Hope AZTR Q1 2026 Earnings Significant EPS Miss and Stock Decline Amid PreRevenue Stage Kyntra Bio Inc KYNB Q1 2026 Earnings WiderthanExpected Loss Fails to Dampen Investor Sentiment Green Plains GPRE Q1 2026 Earnings Massive EPS Beat of 63555 Drives Stock Higher WesBanco WSBC Edges Higher Approaching Resistance After Modest Gains Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted Precigen Inc PGEN Holds Steady at 424 as Stock Nears Key Support Level Hackett Group Inc HCKT Surges 442 Bullish Momentum Tests Key Resistance Willamette Valley Vineyards Preferred Stock WVVIP Slips 344 as Selloff Tests NearTerm Support Fed Faces Tighter Path to Rate Cuts as Jobs Data Highlights Persistent Inflation Concerns Columbia Banking System Inc COLB Q1 2026 Earnings EPS Beats Estimates Amid Steady Operating Performance Voya Global Advantage and Premium Opportunity Fund IGA Holds Steady at 988 Amid RangeBound Trading Li Bang International LBGJ Hovers Near Support Amid Modest Decline Silo Pharma SILO Surges 5 as SmallCap Biotech Recovers From Recent Lows Janus Living Inc JAN Shows Modest Uptick as Stock Trades Near MidRange Blackrock MuniYield Quality Fund III Inc MYI Posts Modest Gain Holding Near Resistance DarioHealth DRIO Slips Over 4 as Selling Pressure Tests Key Support Levels Milestone Pharmaceuticals MIST Slides 724 as Selling Pressure BuildsKey Support at 134 in Focus DexCom DXCM Pulls Back 243 as Stock Approaches Key Support Level